FDA’s Shift From Animal Testing Opens Doors for Organoid Makers

The CNS-3D Induced Alzheimer’s Model is a brain organoid assay enabling researchers to evaluate whether therapeutic candidates can reduce or prevent disease progression in patients.

The only assay-ready immunocompetent 3D brain organoid model incorporating microglia for studies of neuroinflammatory mechanisms and drug efficacy

CNS-3D Myelinated Organoids are designed to quantify drug-induced demyelination, observe natural remyelination, and evaluate therapeutic strategies for myelin repair, capturing both injury and recovery within the same biological context.